Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19. Muralidar S, Gopal G, Ambi SV. J Med Virol 2021 Apr 14. doi: 10.1002/jmv.27019.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Muralidar S, Gopal G, Ambi SV. Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19. J Med Virol 2021 Apr 14. doi: 10.1002/jmv.27019.
PMID: 33851732